|
| Press Releases |
|
 |
|
| Thursday, December 1, 2016 |
|
|
Luye Pharma Announces the Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business |
| Luye Pharma Group Ltd. (2186.HK) is pleased to announce the completion of its acquisition of the transdermal drug delivery systems (TDS) business from Swiss company, Acino. The acquired business is a global leader in niche transdermal markets and will greatly enhance Luye's developmental efforts in R&D, more info >> |
|
| Tuesday, July 26, 2016 |
|
|
綠葉製藥國際化邁出里程碑意義的一步 宣布簽約收購瑞士Acino公司之透皮釋藥業務 |
| 2016年7月25日，綠葉製藥集團有限公司(2186.HK)欣然宣布，與瑞士Acino公司簽約，以2.45億歐元購買旗下透皮釋藥業務，即Acino AG和Acino Supply AG（統稱“標的公司”）全部發行之股本。 more info >> |
|
|
绿叶制药国际化迈出里程碑意义的一步 宣布签约收购瑞士Acino公司之透皮释药业务 |
| 2016年7月25日，绿叶制药集团有限公司(2186.HK)欣然宣布，与瑞士Acino公司签约，以2.45亿欧元购买旗下透皮释药业务，即Acino AG和Acino Supply AG（统称“标的公司”）全部发行之股本。 more info >> |
|
|
Luye Pharma Takes a Milestone Step Forward; Proposed Acquisition of Acino's TDS Business |
Luye Pharma Group Ltd. (2186.HK) (the "Company", and together with its subsidiaries, "Luye Pharma" or the "Group") announces its agreement to acquire the TDS business from Acino, through the purchase of the entire issued share capital of Acino AG and Acino Supply AG (the "Target Group") for EUR245,000,000 (the "Acquisition").
more info >> |
|
| Friday, May 6, 2016 |
|
|
Luye Medical welcomes Australia's Healthe Care to its Group |
| Healthe Care, Australia's third largest private healthcare group, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund completed on April 18. more info >> |
|
| Sunday, April 24, 2016 |
|
|
Singapore-based Luye Medical Group Completes Acquisition of Healthe Care, Australia's Third Largest Private Healthcare Group |
| On April 18, 2016, Australia's third largest private healthcare group, Healthe Care, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund was completed. more info >> |
|
| Friday, October 9, 2015 |
|
|
China's First Innovative Drug Led by Luye Pharma Approved NDA in the U.S. |
| The leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd. (the "Company", together with its subsidiaries, "Luye", stock code: 2186.HK), announced that the United States Food and Drug Administration (the "FDA") has confirmed that no additional clinical trials are needed for the New Drug Application ("NDA") submission for Risperidone Extended-release Microspheres for Injection ("LY03004") in the U.S. more info >> |
|
|
由綠葉製藥研發的我國首個創新藥獲批在美提交新藥申請 |
| 以研發為驅動，以國際化為目標的中國領先創新製藥企業--綠葉製藥集團(簡稱「公司」，連同其附屬公司，統稱「綠葉」，股份代號：2186.HK)，近日宣佈，美國食品藥品監督管理局（FDA）確認公司研發的利培酮微球注射劑（LY03004）不需再進行任何臨床試驗，可在美提交新藥申請（NDA）。 more info >> |
|
| Tuesday, June 2, 2015 |
|
|
綠葉製藥宣佈終止收購北京嘉林藥業股權之協議 |
以研發為驅動，以國際化為目標的中國領先創新製藥企業--綠葉製藥集團(股份代號：2186.HK)宣佈，終止收購北京嘉林藥業股份有限公司之股權協議。公司股票在短暫停牌後於今日恢復交易。
more info >> |
|
| Thursday, May 14, 2015 |
|
|
綠葉製藥被納入MSCI中國指數 |
| 以研發為驅動，以國際化為目標的中國領先創新製藥企業--绿叶制药集团(股份代號：2186.HK)宣佈绿叶獲納入摩根士丹利資本國際(「MSCI」)環球標準指數系列中的中國指數成分股，將於今年5月29日收市後生效 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
国资护航+技术壁垒+优质保荐 华芢生物（02396.HK）PDGF管线直指18A赛道确定性价值
Dec 15, 2025 11:05 HKT/SGT
|
|
|
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Dec 15, 2025 09:51 HKT/SGT
|
|
|
國資護航+技術壁壘+優質保薦 華芢生物（02396.HK）PDGF管線直指18A賽道確定性價值
Dec 15, 2025 09:28 HKT/SGT
|
|
|
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
Dec 15, 2025 8:30 JST
|
|
|
韓国の主要人物・金載德氏がMOVA Chain支援を表明、エコシステム発展が新段階へ
Dec 13, 2025 13:00: JST
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
|
|
|
京東工業登陸港交所：業績與品牌雙賦能 長期成長潛力可期
Dec 12, 2025 17:05 HKT/SGT
|
|
|
京东工业登陆港交所：业绩与品牌双赋能 长期成长潜力可期
Dec 12, 2025 17:04 HKT/SGT
|
|
|
京東工業配售結果出爐：MRO龍頭實力領跑 全鏈條數智化解決方案釋放長期價值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
京东工业配售结果出炉：MRO龙头实力领跑 全链条数智化解决方案释放长期价值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
全鏈條服務+業績高增長彰顯實力 京東工業港交所上市釋放長期價值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
全链条服务+业绩高增长彰显实力 京东工业港交所上市释放长期价值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
首隻山水實景表演概念股 印象大紅袍啟動香港公開募股
Dec 12, 2025 15:01 HKT/SGT
|
|
|
首只山水实景表演概念股 印象大红袍启动香港公开募股
Dec 12, 2025 15:00 HKT/SGT
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
